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2. Polyphasic taxonomy grounds on:
1. Phylogenetic relationships among bacterial groups
2. Genetic analysis of bacteria including DNA-DNA hybridization and 
ribotyping
3. Specific protein and enzyme patterns of bacteria
4. Specified number of phenotypic traits
5. All above listed is relevant+




3. Microscopy with differential stains
4. Identification of chemical composition of bacteria 
(chemotaxonomic markers)
5. Full description of expressed features (morphology and physiology, 
antigenic structure of bacteria, etc.)







5. “Genle-Koch’s triad” formulates:
1. Conditions for epidemic process development
2. Basic principles that prove infectious origin of the disease+
3. Basic principles of asepsis
4. Principles of laboratory testing in microbiology
5. Basic three-domain organization of microbial world






7. Bacterial strain is:
1. Population of bacteria of the same species inhabiting common area
2. Population of bacteria that exert the same pathology
3. Population of bacteria of the same species isolated from various 
sources
4. Population of bacteria of the same species isolated from various 
sources or from the same source at different periods of time+
5. Population of bacteria with closely similar genomic features
8. Biovar of bacteria means:
1. Group of bacteria sharing biochemical features with other bacteria:
2. Bacteria with common metabolic pathways
3. Group of the same species bacteria with common special 
biochemical or physiologic properties+
4. Bacteria living in the same biotope
5. Various bacteria forming common biofilm
5
9. Resolving power of light microscope is determined by:
1. Wavelength of light
2. Light wave frequency
3. Refraction index of medium
4. Wavelength of carrier light and numeric aperture of objective lens+
5. Overall magnification of objective and ocular lenses
10. Microscopical technique allowing the formation of 3D-like relief image 
of cells:
1. Bright field microscopy
2. Dark field microscopy
3. Fluorescent microscopy
4. Phase contrast microscopy
5. Differential interference contrast (DIC) light microscopy+
11. Light microscopical technique for real-time observation of living 
bacteria:
1. Phase contrast microscopy+
2. Bright field transmission light microscopy -  simple stain
3. Bright field microscopy -  differential stain
4. Transmission electron microscopy
5. Scanning electron microscopy






5. All are presented
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13. Numerical taxonomy is primarily based on:
1. Morphology of bacteria
2. Multiple biochemical markers
3. Sequencing of bacterial genomes
4. Antigenic structure
5. Computer-assisted analysis of all traits of bacterial population+
14. Current method providing classification of bacteria on species level:
1. Electron microscopy
2. Identification of chemical composition of bacteria 
(chemotaxonomic markers)
3. Full description of expressed features of bacteria (morphology and 
physiology, antigenic structure, etc.)
4. DNA-DNA hybridization+
5. Ribotyping






16. Choose incorrect statement:
1. Paul Ehrlich was the first who introduced chemical drugs for 
infectious disease treatment
2. Ilya MetchnikofF discovered phagocytosis
3. Alexander Fleming discovered sulfonamides+
4. Ignaz Semmelweis formulated first principles of asepsis
5. Joseph Lister demonstrated high efficacy of antiseptics in 
prevention of wound infections
7
1. Common origin
2. Evolutionary stable genomic organization+
3. Genomic DNA relatedness at 70% or more
4. Similar or common area of habitation
5. Similar properties
17. These features are essential for species in bacteria except:
18. Fathovar of bacteria means:
1. Various bacteria isolated from patients with certain disease
2. Various bacteria producing similar toxins or other virulence factors
3. Degraded morphological form of bacteria
4. Bacteria of the same species with equal spectra of antibiotic 
resistance
5. Bacteria of the same species demonstrating equal pathogenic 
properties for certain hosts+
19. Total magnification of light microscopes is calculated as:
1. Magnification of objective lens multiplied by magnification of 
eyepiece lens+
2. Magnification of objective lens multiplied by magnification of 
condenser and eyepiece lens
3. Overall magnification of objective and eyepiece lenses divided by 
focal length
4. Total sum of objective, eyepiece and condenser lens magnifications
5. Total sum of objective and eyepiece lenses multiplied by power 
coefficient of light source
20. Microscopical technique that creates true 3D-image of bacteria:
1. Differential interference contrast (DIC) microscopy
2. Laser scanning confocal microscopy+
3. Fluorescent microscopy
4. Phase contrast microscopy
5. Transmission electron microscopy
21. Microscopical technique allowing real-time analysis of microbial 
surface on nanoscale level:
1. Atomic force microscopy+
2. Transmission electron microscopy
3. Differential interference contrast (DIC) microscopy
4. Laser scanning confocal fluorescent microscopy
5. Immune fluorescent microscopy
22. Microscopical technique with highest resolving power:
1. Differential interference contrast (DIC) microscopy
2. Scanning electron microscopy
3. Transmission electron microscopy+
4. Laser scanning confocal microscopy
5. Fluorescent microscopy





5. Granules of volutin






25. A method of studying of bacterial morphology
1. Inoculation into solid medium
2. Serological testing
3. Genetic identification
4. Preparation of smears with simple method of stain+
5. Biochemical reactions
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26. The mechanism of penicillin action
1. Termination of nucleoid replication
2. Prevention of capsule synthesis
3. Osmotic shock
4. Impairment of cell wall synthesis due to transpeptidase inhibition+
5. Dampening of protein synthesis


















30. Morphology of streptococci
1. Chains of cocci+
2. Paired cocci
3. Tetrade-forming cocci
4. Cocci, lying separately from each other
5. Grapes-like cocci
10












33. Structure for protection of bacterial cells against macrophages
1. Flagella
2. Cytoplasmic membrane
3. Granules of volutin
4. Capsule+
5. Ribosomes






























39. Morphology of staphylococci:
1. Chains of cocci
2. Paired cocci
3. Tetrade-forming cocci
4. Cocci, lying separately from each other
5. Grapes-like cocci+



















43. L-form of bacteria means:
1. Bacteria without capsule
2. Lamellar bacterial form
3. Non-replicating dormant bacteria
4. LPS-containing bacteria
5. Bacteria without cell wall able to self-replication+




4. Teichoic acids +
5. Outer membrane













47. For fungi is typical:
1. Presence of nucleus+
2. Presence of nucleoid
3. Presence of flagella
4. Presence of teichoic acids
5. Absence of cell wall



















































































5. By means of spores






63. A method for rickettsia cultivation:
1. Basic nutrient media










65. A method for detection of spirochetes motility:
1. Romanovsky-Giemsa stain

















































2. Degradation of biopolymers
3. Energy liberation
4. Peptide chain elongation+
5. Hydrolysis of macromolecules
74. Asepsis means:
1. Eradication of pathogenic microorganisms in the environment by 
chemical compounds
2. Elimination of the invaded microbes from the body
3. Termination of bacterial and fungal growth in wounds with 
chemical substances
4. Treatment of sepsis
5. Complex of measures, preventing microbial contamination of any 




1. Nutrition process without energy consumption
2. Mechanism of nutrition based on group translocation
3. Simultaneous transport of two substances in opposite directions
4. Movement of bacterial cells in the same direction
5. Parallel transportation of two substances in the same direction+






77. Catabolism provides for microorganisms:
1. Protein synthesis
2. Any macromolecule synthesis
3. ATP accumulation+
4. Supply with growth factors
5. Nucleoid replication





5. All above mentioned+




















1. Liquidation of vegetative microbial forms and their spores in 
various materials with heating;
2. Number of measures for eradication of microbial species from 
objects in external environment by chemical compounds or physical 
methods+
3. Complete elimination of all microbial forms
4. Killing of bacteria directly in the wounds by chemical substances
5. Complex of measures for eradication of microbial pathogens from 
human body by chemical drugs or physical methods





5. Heating with hot air in Pasteur chamber+
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1. Anti-microbial intervention dampening trans-membrane 
transportation in bacteria
2. Nutrition of bacteria without energy consumption
3. Simultaneous transportation of two substances in opposite 
directions+
4. Simultaneous transport of two substances in the same direction
5. Inhibition of bacterial motility
84. Antiport means:






86. Method of non-complete sterilization:
1. Autoclaving under pressure;
2. Gamma-irradiation;
3. Heating in Pasteur oven
4. Boiling+
5. Tindalization


























91. Medium for strict anaerobes cultivation:










5. Presence of flagella
23

















































101. Method for anaerobes cultivation:
1. In aerobic jar
2. In Pasteur chamber
3. In deep agar culture of Wilson-Blair medium+
4. In Petri dish with MPA
5. In test tube with MPB


















4. Resistance to antibiotics
5. Rough surface+
105. The most beneficial pathway for energy gain in bacteria:
1. Embden-Meyerhoff pathway































2. Low molecular weight
3. Thermostability
4. High binding to transition state of substrate+
5. High binding to product
111. Enzymes of protein synthesis:
1. Exo-enzymes
2. Connected with ribosomes+
3. Localized in cell membrane
4. Localized in mesosomes
5. Attached to nucleoid
112. Oxyreductases:
1. Accelerate processes of synthesis
2. Break bonds between carbon atoms in molecule
3. Move residues from one molecule to another
4. Attach water molecule to substrate
5. Accelerate reactions of electron loss or acquisition+
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113. Lyases:
1. Break bonds in molecules with hydrolytic mechanism
2. Break bonds in molecules with non-hydrolytic mechanism*
3. Transfer atoms between groups in molecule
4. Accelerate redox processes
5. Join one molecule to another
114. Hydrolases:
1. Accelerate synthesis of complex substances from simple ones
2. Break bonds in molecules with non-hydrolytic mechanism
3. Break bonds in molecules with water molecule loss
4. Break bonds in molecules with water molecule attachment*
5. Accelerate oxidative and reductive processes












117. Test substance for H2S determination after proteolysis:
1. Lead acetate -  black colour*
2. Oxalate -  red colour
3. Bromide cresol blue -  purple
4. Lachmus -  blue colour
5. Silver nitrate -  white




















2. Stabilize transition state of substrate+
3. Low molecular weight
4. Thermostability
5. Increase energy of substrate activation
122. Enzymes of energy metabolism:
1. Exo-enzymes
2. Localized in ribosomes
3. Localized in cell membrane+
4. Responsible for protein synthesis
5. Accelerate microbial spread in affected host
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123. Transferases:
1. Accelerate synthesis of complex substances
2. Disrupt bonds between nitrogen and carbon atoms by non- 
hydrolytic manner
3. Provide movement of chemical groups from one molecule to 
another+
4. Accelerate redox reactions
5. Catalyze transfer of chemical groups within the same molecule
124. Lygases:
1. Catalyze synthesis of complex molecules from more simple ones+
2. Transform molecules into their isomers
3. Transpose atoms between molecules
4. Accelerate electron and proton transfer
5. Catalyze the decay of complex molecules
125. Isomerases:
1. Stimulate joining of various molecules
2. Accelerate the transfer of chemical groups or atoms within a single 
molecule+
3. Transfer chemical groups between various molecules
4. Convert polymers into monomers
5. Provide substrate oxygenation













128. Indicator for indole determination after proteolysis:
1. Lead acetate -  black colour
2. Fuchsin -  red colour
3. Oxalate -  pink colour+
4. Bismuth sulfite -  black colour
5. Lachmus -  blue colour



















1. Bacteria don’t influence one another
2. One of symbionts exploits another one without harmful effect+
3. Both beneficial co-existence
4. Two species stimulate one another with additional activating effect
5. Microbial species exploits another one with harmful effect
133. Neutralism means:
1. Bacteria don’t influence one another+
2. One of symbionts exploits another one without harmful effect
3. Both beneficial co-existence
4. Two species stimulate one another with additional activating effect
5. Microbial species exploits another one with harmful effect
134. Model sanitary microorganisms are:
1. Pathogenic bacteria
2. Saprophytic bacteria
3. Representatives of normal microflora+
4. Hospital ecovariants of bacteria
5. Free-living environmental bacteria
135. Total microbial count for air:
1. Total microbial quantity freely sedimented from air upon 1 m2 of 
ground area
2. Total microbial quantity in 1 m3 of air+
3. Total microbial quantity in 1 liter of air
4. Total microbial quantity in 1 cm3 of air
5. Total microbial quantity in certain room
136. Model sanitary microorganisms for air quality testing:
1. Aerococci
2. Escherichia coli




137. Total microbial count for water:
1. Quantity of mesophilic chemoorganotrophic bacteria in 1 ml of 
watert-
2. Quantity of mesophilic chemoorganotrophic bacteria in 100 ml of 
water
3. Quantity of mesophilic chemoorganotrophic bacteria in 1 liter of 
water
4. Quantity of thermophilic bacteria in 1 ml of water
5. Total quantity of thermotolerant bacteria in 1 liter of water
138. Method for testing of air sanitary quality:
1. Titration method
2. Membrane filtration method
3. Serial dilution method
4. Inoculation into Kessler medium
5. Aspiration method+
139. Model sanitary microorganisms for hand wash testing:
1. Coliform bacteria











1. Bacteria produce antibiotic substances in spite of rival presence in 
the medium+
2. Bacteria synthesize antibiotics only when another microorganism 
appear in closest proximity
3. Microorganisms produce antibiotics being cultured in starvation
4. Microorganisms produce antibiotics when grown on selective media
5. Bacteria secrete antibiotics inconstantly, sometimes
141. Overt antagonism means:
142. These elements comprise the common ecosystem except
1. Microbial communities
2. Biotope
3. Relationships established among symbiotic microbial populations
4. Competition for nutrients amongst various bacterial species 
inhabiting the same locality
5. Microbial communities inhabiting non-related biotopes+
143. Mutualism means:
1. Bacteria don’t influence one another
2. One of symbionts exploits another one without harmful effect
3. Both beneficial co-existence+
4. Two species stimulate one another with additional activating effect
5. Microbial species exploits another one with harmful effect
144. Synergism means:
1. Bacteria don’t influence one another
2. One of symbionts exploits another one without harmful effect
3. Both beneficial co-existence
4. Two species stimulate one another with additional activating effect+
5. Microbial species exploits another one with harmful effect
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145. Model sanitary microorganisms:
1. Representatives of temporary (or casual) microflora of human body
2. Live longer than pathogenic bacteria
3. Have special reservoir for propagation outside the body
4. Can be easily monitored by standard microbiological tests+
5. Capable of reproduction in the environment












148. This feature is essential for hospital (or nosocomial) strains:
1. Multiple resistance to antibiotics+
2. Survive as planktonic forms
3. Slow production of virulence factors
4. Spore-forming bacteria
5. Circulation in the environment
149. Method for water microbial testing:




5. Deep agar cultivation
35






151. End products of lactose fermentation by coliform bacteria:
1. Gases and acids+
2. Gases only
3. Only acids
4. Neither acids no gases
5. Alcohols and gases
152. Forced antagonism means:
1. Bacteria produce antibiotics in spite of rival presence in the medium
2. Bacteria synthesize antibiotics only in presence of another 
microorganism+
3. Microorganisms produce antibiotics being cultured in starvation
4. Microorganisms produce antibiotics when grown on selective media
5. Bacteria occasionally secrete antibiotics

























157. Genetic resistance to antibiotics emerges after:
1. Plasmid acquisition after conjugation*
2. Inhibition of antibiotic influx
3. Acceleration of synthesis of molecular targets for antibiotic




2. Erythromycin in low doses
3. Sulfamethoxazole
4. Chloramphenicol
5. None from above listed*






160. Methods for MIC determination:
1. Disk diffusion method
2. Immune diffusion method
3. Serial dilution method+
4. Neutralization method
5. Biological method

















5. None of listed above
164. Levels of minimal bactericidal concentration in comparison with 
minimal inhibitory concentration are:
1. Less than
2. Equal or less
3. Equal
4. Equal or more+
5. More
38





























5. Amphotericin A and В
170. First stage o f  beta-lactam antibiotics action:




5. Activation of trans-membrane channels
171. Side effects of antibiotic therapy:
1. Allergic reactions
2. Direct toxic effects
3. Antibiotic resistance development
4. Endotoxic shock emergence
5. All above listed+


















1. Disc diffusion test
2. E-test+
3. Immune diffusion test
4. Agar serial dilution test
5. Broth serial dilution test
175. Diffusion antibiotic susceptibility test with MIC determination:




















179. What statement isn’t true:
1. Genes, essential for bacterial metabolism, are localized mainly in 
nucleoid
2. Autonomous bacterial replicons able to integrate to nucleoid are 
named episomes
3. Bacterial genome is diploid+
4. Bacterial genetic information is stored in DNA
5. Bacterial DNA replication starts from o h  locus
























5. F-factor integration into nucleoid+






5. None of above listed




4. Amplification cycle repeat
5. Reverse transcription+



















189. Genetic sequence in operon that accelerates transcription via the 






190. The structure that not pertains to plasmids:
1. F-factor
2. R-factor
3. Factor of bacteriocinogenesis
4. Competence factor+
5. Col-factor























4. Donor’s DNA uptake+
5. None of listed above






196. Hybridization technique is based on:
1. Gene transfer by vectors
2. Genetic recombination
3. DNA or RNA interaction with complementary probe+
4. DNA amplification
5. Genetic transposition
197. Most rapid method of genetic sequencing:
1. Sanger’s method
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2. Cell subsets of immune system bearing Ag-specific receptors:
1. Mononuclear phagocytes system
2. Granulocytes system
3. Natural killer cells
4. T and В cells+
5. Platelets system
3. Natural active immunity is developed via:
1. Breast feeding
2. After vaccination
3. After infectious disease+
4. From mother to fetus
5. After immunoglobulin administration
4. Artificial passive immunity is obtained:
1. After infectious disease
2. After vaccination
3. Due to immunoglobulin administration+
4. After toxoids injection
5. From mother to fetus
5. Respiratory burst means:
1. Biological oxidation in bacteria
2. Mitochondrial respiration in lymphocytes
3. Activation of reactive oxygen species in phagocytes+
4. Oxidative phosphorylation in phagocytes
5. Oxygenation of lymphoid tissue




























3 .  CD40
4. CD 19-22
5. CD95






















4 .  CD5
5. CD8+
48

















5. All above-mentioned is correct+













1. From mother to fetus through placenta+




20. Natural passive immunity is obtained after:






22. Anti-bacterial substances that exert microbial degradation within 




4. Reactive oxygen species+
5. Opsonins
23. Properties of complete antigens:
1. Doesn’t need carrier+
2. Doesn’t need their own presentation for T cells
3. Presumably of lipid origin
4. Non-charged linear molecules
5. Low molecular weight polysaccharides
50













26. Cells bearing major histocompatibility complex class II antigens:















4. TCR specifity assessment
5. Coombs’ test
51
29. Erythrocyte antigenic diagnosticum is used for:
1. Extended agglutination reaction
2. Indirect hemagglutination test+
3. Direct hemagglutination test
4. Hemolysis reaction
5. Tentative slide agglutination reaction







1. Up to 2% of common T-cells activation
2. Up to 20% of common T-cells activation+
3. В-cells activation
4. Classic pathway complement activation
5. IL-4 and IL-10 secretion
32. CD8+ cells recognize antigen peptide in complex with:
1. TAP-Ag
2. IL-2 receptor
3. HLAI class Ag+
4. HLA II class Ag
5. Without any complexing






5. Within membrane vesicle
52
34. Hapten is characterized by:
1. Strong immunogenicity
2. Complete antigen
3. High molecular weight
4. Needs adjuvants
5. Needs carrier+












37. Thymus-independent antigens directly induce immune response of:
1. Neutrophils

















1. Ability to specific binding of Ag to antibodies
2. To induce specific response of T and В cells*
3. To trigger phagocytosis
4. To activate complement system
5. To induce tolerance






42. Bacterial specific agglutionation is possible due to:
1. Termination of bacterial movement
2. Low salt concentration
3. Lowering of pH
4. Specifity of antibodies
5. Multivalent specific interaction of bacteria with complete 
antibodies*
43. Erythrocyte antigenic diagnosticum means:
1. Antigens of erythrocytes
2. Erythrocytes attached to polymeric microbeads
3. Ist blood group erythrocytes
4. Erythrocytes linked with specific antigens*
5. Erythrocytes with attached specific antibodies
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44. Antibodies against human immunoglobulins are used in:
1. Slide agglutination test
2. Extended test tube aglutination
3. Blood groups determination
4. Widal’s reaction
5. Coombs’reaction+


















48. Serum IgG concentration:
1 . 8 -12  g/l+






















5. Two antibody-secreting cell lines fusion
52. Toxigenicity of diphtheria bacilli culture is determined by:
1. Agglutination reaction
2. Indirect hemagglutination assay
3. Neutralization reaction+
4. Radial immune diffusion
5. Immune electrophoresis







54. Reagent for neutralization reaction:
1. Diagnosticum









5. Complement fixation test
56. Antigen-binding site of antibody is formed by:
1. Domains of L-chain
















59. Serum IgM concentration:
1 . 8 -12  g/1
2. 0-100 ME
3. 0,01-0,04 g/1 
4.2-4 g/1
5. 0,8-1,5 g/l+
60. The main advantage of immune electrophoresis:
1. Rapid test
2. High sensitivity
3. One-step solid phase test
4. Able to identify particular antigens in complex antigenic mixture+
5. Easy performance and low cost






62. Immunoglobulin G concentration is determined by:
1. Neutralization reaction
2. Precipitation reaction
3. Mancini radial immune diffusions-
4. Ouchterloni double immune diffusion
5. Indirect hemagglutination reaction
63. Double immune diffusion can be used for:
1. Antibody or antigen determination+
2. Microbial identification
3. Blood group determination
4. Identification of cellular sub-populations
5. Incomplete antibodies determination
58




4. Immune phagocytosis activation+
5. Acceleration of antigen processing




4. Serum containing active complement
5. Viral diagnosticum
66. Monoclonal antibodies used for treatment of human diseases are:
1. Of mouse origin “humanized” by genetic engineering+
2. Of mouse origin
3. Of human origin
4. Of rabbit origin
5. Obtained from myeloma cell lines




3 .  C3+
4 .  C4
5 . C5







69. W assermann reaction means:
1. Complement fixation test for serologic diagnosis of syphilis+
2. Complement fixation test for influenza diagnosis
3. Direct fluorescent-antibody testing against T. pallidum  in syphilis
4. Tube agglutination test for antibodies in enteric typhoid fever
5. ELISA IgM antibody test for diagnosis of congenital syphilis
70. Hemolysis reaction is used for:
1. Bacteriolysis test




71. Reagent for indirect immune fluorescence test:
1. Anti-globulin labeled with enzyme
2. Anti-globulin labeled with isotope
3. Anti-globulin labeled with 125I
4. Anti-globulin labeled with horseradish peroxidase














74. Anti-globulin serum is obtained by:
1. Immunization of rabbits with erythrocytes
2. Immunization of rabbits with human antibodies+
3. Immunization of rabbits with globular synthetic microbeads
4. Immunization of mice with hapten
5. Immunization of goats with mouse albumin
75. First step for immunoblotting:
1. Immune electrophoresis
2. Radial immune diffusion
3. Indirect enzyme-linked immune assay
4. Polyacrylamide electrophoresis+
5. Ascoli’s test




4. Anti-globulin labeled with FITC
5. Anti-globulin labeled with iodine






78. Classic pathway of complement activation is initiated by:
1. Antibodies
2. Antigens
3. Immune complex formation+
4. Toxins
5 . LPS
79. Immunological test allowing determination of any cell sub-population 
by identification of its membrane CD molecules:
1. Radioimmune assay
2. ELISA test
3. Indirect immune fluorescence test with monoclonal antibodies+
4. Indirect hemagglutination test
5. Complement fixation test
80. In classic pathway C lq subunit is attached to:
1. CH3 Ig domain
2. CH2 Ig domain+
3. CHI Ig domain
4. VL domain
5. CL domain





5. All mentioned above+





5. Decay accelerating factor (DAF)
83. Cell lysis due to complement action is performed by:






84. Indicator system for complement fixation test:
1. Complement system
2. Sheep red blood cells with hemolytic serum+
3. Sheep red blood cells
4. Hemolytic serum
5. Fluorescent label







86. Hemolytic serum is obtained by:
1. Immunization of rabbits with microbial cells
2. Immunization of mice with bacteria
3. Immunization of rabbits with human erythrocytes
4. Immunization of mice with complement
5. Immunization of rabbits with sheep erythrocytes+





5. None of listed above
88. Tests with labeled antibodies or antigens predominate in current 
laboratory immunology owing to:
1. Easy use
2. Low cost
3. Automatic computer-assisted detection
4. Superior tests efficacy (highest sensitivity, specificity, 
reproducibility)+
5. Capabilities of mass screening
89. T-independent immune response results in production of:
1. IgM class antibodies+
2. IgG class antibodies
3. IgA class antibodies
4. IgG and IgA class antibodies
5. All of above listed
90. Predominant cytokine promoting immunoglobulin class switch from 










4. Natural killer cells
5. Plasma cells
64





5. All above listed+
93. Immunologic synapse comprises:
1 . TCR, processed antigenic peptide, CD4 or CD8 molecules, co­
stimulatory molecules
2. TCR, HLA molecule, native antigen
3. TCR, HLA molecule, processed antigenic peptide, CD4 or CD8 
molecules
4. TCR, HLA molecule, native antigen, CD4 or CD8 molecules
5. TCR, processed antigenic peptide, HLA molecule, CD4 or CD8 
molecules, co-stimulatory molecules+




3. Cell unresponsiveness (anergy)+
4. Cell proliferation
5. Active cytokine secretion
95. T-dependent immune response comprises below listed phases except:
1. Sensitization phase+
2. Processing and presentation of the antigen




96. Function of proteasome:
1. Scavenging and hydrolysis of extracellular proteins
2. Digestion of intracellular misfolded or alterated proteins
3. Scavenging of cellular alterated proteins as well as processing of 
intracellular antigens followed by HLA-I dependent presentation+
4. Digestion of intracellular peptides for energy gain
5. Compartment for isolation of cellular proteases
97. Potent cytokines suppressing immune reactions:
1. IL-4, IL-5, IL-6
2. IL-17, IL-18
3. IL-10, P-TGF+




2. Immune complex reactions
3. Transformation of В cells into plasma cells
4. Delayed hypersensitivity+
5. Immediate hypersensitivity
99. Essential cytokines of Th2:
1. IL-4, IL-5, IL-10, IL-13+
2. IL-2, y-interferon, P-TNF
3. IL-1, IL-6, IL-12, IL-18, a-TNF
4. IL-10, p-TGF
5. EGF, TGF, a-interferon, p-interferon







101. TLR-4 specifically binds to:





102. TLR-2 specifically binds to:
1. Viral double-stranded RNA
2. Bacterial DNA
3. Lipoproteins, lipoteichoic acids, peptidoglycan+
4. Flagellin
5. Bacterial LPS
103. Main cellular reaction of innate immunity against bacterial infections:
1. Complement activation
2. Synthesis of antibodies of IgM, IgG, and IgA classes by plasma 
cells
3. Activation of cytotoxic T cells
4. Phagocytosis+
5. Acute-phase protein synthesis






105. Memory T-cells bear the receptor:
1- IgG
















5. All above listed+
108. Anti-idiotypic antibodies suppress:
1. Primary antibodies triggered by antigenic epitopes+
2. Phagocyte activity
3. Complement activation
4. Abnormal neuronal proteins in CNS disorders
5. Cytokine secretion
109. Essential cytokines of Thl:
1. IL-2, y-interferon+
2. IL-4, IL-10, IL-13, IL-15
3. IL-1, IL-6, IL-12, IL-18, a-TNF
4. IL-10, p-TGF
5. IL-3, IL-7




4. T cytotoxic cells
5. NK-cells
68




















114. Normal value of Th/Tc ratio (immunoregulatory index):




5. More than 3,0
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115. Secondary immunodeficiences are stimulated by:
1. Viral infections
2. Chemical environmental pollution
3. Radiation
4. Immunosupressive drugs treatment
5. All above listed+
116. Immediate hypersensitivity manifests after antigenic stimulation
1.30 min -  16 h+
2. 24 h -  36 h
3. 36 h -4 8  h 
4.48 h -  72 h 
5. About 5 days
117. Main autoantigen for systemic lupus erythematosus:







2. Yellow lever vaccine
3. Hepatitis В vaccine+
4. Smallpox vaccine
5. Anthrax vaccine
119. Functional test for activity of T- or В cells:
1. Complement fixation test
2. Test of lymphocyte blast transformation+
3. Agglutination test
4. NBT test
5. Immune fluorescence with anti-CD4 or anti-CD8 mAbs
120. The function o f autoantibody known as LATS-factor:
1. Stimulation of lactation
2. T lymphocyte activation
3. Cytotoxic effect against thyroid cells
4. Cytotoxic effect in lateral amiotrophic sclerosis
5. Activation of thyrotropin receptors in thyroid gland+





































127. Tularin skin test evaluates:
1 . 1 st type of hypersensitivity
2 . 2 nd type of hypersensitivity
3. 3rd type of hypersensitivity
4. 4th type of hypersensitivity+
5. 5th type of hypersensitivity






5. Stimulatory and blocking hypersensitivity




4. Immune complex-mediated reactions+
5. Antibody-dependent cell cytotoxity (ADCC)
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130. BCG is used for:
1. Tuberculosis specific prophylaxis+
2. Skin testing in tuberculosis
3. Tuberculosis chemotherapy
4. Specific tuberculosis treatment
5. Serologic diagnosis of tuberculosis





5. Fc-fragment of human immunoglobulins+
132. NBT test evaluates
1. Respiratory burst in phagocytes+
2. B- and T cell proliferation
3. Phagocyte number
4. Leukocyte migration
5. Presentation of antigens
133. Condition, necessary for infectious process development:
1. Body susceptibility to certain pathogen+
2. Source of infection presence
3. Susceptible population presence
4. Mechanisms of disease transmission
5. Vector presence



























1. Protein synthesis inhibition
2. Proteolytic degradation of neuronal proteins+
3. Disruption of cell membrane
4. Superantigen action
5. Activation of secondary messengers














1. Bacteria enter the blood stream, but not multiply there+
2. Bacteria enter the blood stream being able to propagate in blood
3. Bacteria are able to propagate in the blood with purulent foci 
creation
4. Bacteria produce toxins in blood
5. Bacteria persist in blood cells, e.g. phagocytes












144. Condition, necessary for epidemic process development:
1. Pathogenic causative agent presence
2. Source of infection presence+
3. Organism susceptibility to certain pathogen
4. Presence of the reservoir of infection
5. Pathogen’s ability to penetrate and invade the body
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147. Cellular sites for superantigen binding:
1. В cell Ab receptor
2. CD16 on granulocytes
3. T cell receptor, variable domains+
4. T cell receptor, constant domains
5. Integrin receptor upon dendritic cells




4. Nausea and vomiting
5. Skin rashes
149. Diphtheria toxin action:
1. Intracellular protease activity
2. Disruption of cell membrane
3. Activation of secondary messengers
4. Protein synthesis inhibition+
5. Superantigen action













1. Bacteria enter the blood stream, but not multiply there
2. Bacteria enter the blood stream being able to propagate in blood+
3. Bacteria are able to propagate in the blood with purulent foci 
emergence
4. Bacteria produce toxins in the blood
5. Bacteria persist in organs or tissues







154. Pathogenic activity of injectisome as function of bacterial type III 
secretion system:
1. Antibiotic secretion
2. Targeted delivery of virulence factors (effector proteins) into 
affected cell+
3. Excretion of bacterial wastes (scavenging function)
4. Transfer of bacterial nucleic acids into target cell




1. Typical morphology of staphylococci:
1. Gram-negative micrococci
2. Gram-positive long chains
3. Gram-positive grape-like assembled cocci+
4. Gram-negative tetrads
5. Gram-positive bundle of cocci
















4. Inhibitor of cellular protein synthesis
5. Metal-dependent protease
5. Mechanism of staphylococcal toxic shock syndrome toxin action:
1. Pore-forming toxin
2. Activator of secondary intracellular messengers
3. Inhibitor of cellular protein synthesis
4. Metal-dependent protease
5. Superantigen+
6. Specific infection caused by S. aureus:
1. Staphylococcal abscess





1. Pseudomonas aeruginosa is a wide spread nosocomial pathogen
2. Pseudomonas aeruginosa produce potent exotoxins
3. Pseudomonas aeruginosa readily survives in the environment
4. Pseudomonas aeruginosa ferments glucose+
5. Pseudomonas aeruginosa displays extremely high resistance to 
antibiotics




















11. Genetic alteration in MRSA staphylococci
1. Acquisition of beta-lactamase genes
2. Acquisition of R-plasmid
3. Alteration of genes controlling antibiotic efflux
4. Phase variation of genes encoding peptidoglycan synthesis
5. Carriage of gene encoding low-affinity PBP2a transpeptidase+
12. Typical morphology of Pseudomonas aeruginosa:
1. Gram-negative non-motile rods
2. Gram-positive motile rods
3. Gram-negative streptobacteria
4. Gram-negative monotrichate bacteria+
5. Gram-positive motile bacteria
13. These staphylococci are coagulase-negative except:
1. S. aureus+




14. Selective medium for Pseudomonas aeruginosa:
1. Blood agar
2. Yolk-salt agar




15. Mechanism of staphylococcal alpha-toxin action:
1. Superantigen
2. Pore-forming toxin+
3. Activator of secondary intracellular messengers
4. Inhibitor of cellular protein synthesis
5. Metal-dependent protease
16. Mechanism of Pseudomonas aeruginosa exotoxin A action:
1. Pore-forming toxin
2 . Superantigen
3. Inhibitor of cellular protein synthesis+
4. Activator of secondary intracellular messengers
5. Metal-dependent protease
17. Severe infection, caused by S. epidermidis:
1. Pneumonia in farmers
3. Wound infections in surgical patients
2. Endocarditis in patients with prosthetic devices+
4. Periostitis in soccer players
5. Scalded skin syndrome in newborns





5. None of above listed
19. Laboratory method for rapid diagnosis of anaerobic infections:
1. Hemagglutination inhibition test
2. Anaerobic jar cultivation

























4. Gram-positive grape-like assembled cocci
5. Gram-positive tetrads





5. It is out of Lancefield classification+
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27. Mechanism of action of streptococcal pyrogenic exotoxins A and C:
1. Pore-forming toxins
2. Activators of secondary intracellular messengers
3. Superantigens+
4. Inhibitors of cellular protein synthesis
5. Metal-dependent protease
28. Major mechanism of streptococcal M protein action:
1. Superantigen
2. Impairment of streptococci opsonization+
3. Hydrolysis of human IgG
4. Activation of tissue metalloproteases
5. Cell membrane damage
29. Serologic diagnosis of streptococcal infections is performed by:
1. Anti-pyrogenic toxin test
2. Anti-M protein test
3. Anti-lipoteichoic acid test
4. Anti-streptolysin О test+
5. Capsule swelling reaction
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4. Eosyne-methylene blue agar
5. Milk agar
31. Survival time for clostridia spores in the environment:
1 . 1 week
2 . 1 month
3. Several months
4. About 1 year
5. More than 1 year+












34. Typical morphology of Clostridium peifringens:
1. Gram-negative non-motile sporeforming rods
2. Gram-positive non-motile sporeforming rods+
3. Gram-positive motile sporeforming rods
4. Gram-positive streptobacteria
5. Gram-negative motile bacteria










4. Potent proteolytic activity
5. CAMP-test
37. Mechanism of perfringens alpha-toxin action:
1. Superantigen
2. Guanylate cyclase activation
3. Inhibitor of cellular protein synthesis
4. Metal-dependent protease
5. Enzyme with phospholipase activity+
38. Mechanism of action of streptococcal pyrogenic exotoxin В
1. Pore-forming toxin
2. IL-1-affecting cystein proteinase+
3. Superantigen
4. Activator of secondary intracellular messengers
5. Inhibitors of cellular protein synthesis





5. Scalded skin syndrome
40. Major mechanism responsible for rheumatic heart disease 
development:
1. Streptococcal hemolysin action
2. Specific streptococcal proteolysis of heart tissues
3. Molecular mimicry of streptococcal M protein with heart tissue 
substances+
4. Streptodomase action, resulting in cell DNA hydrolysis
5. Direct cell membrane damage
41. Laboratory method for determination of tetanus toxin strength:
1. Slide agglutination




42. DPT vaccine is composed of:
1. Tetanus, pertussis and diphtheria toxoids
2. Killed streptococci of D group, killed pertussis bacteria, tetanus 
toxoid
3. Killed bacteria of tetanus, pertussis and diphtheria
4. Killed pertussis bacteria, tetanus and diphtheria toxoids+
5. Killed pneumococci, tetanus and diphtheria toxoids
43. Antibiotics for treatment of enterococcal infections:




5. Combination of cephalosporins and tetracyclines
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44. Cornerstone in urgent therapy of tetanus:
1. Toxoid administration
2. Anti-toxic antibodies administration+
3. Antibiotic treatment
4. Infusive detoxication therapy
5. Sedative therapy
45. Typical morphology of E. colt.
1. Gram-positive motile rods
2. Gram-negative motile rods-t-
3. Gram-negative non-motile rods
4. Gram-positive non-motile rods
5. Gram-negative motile diplobacteria






47. Antigen composition of E. colt
1. O-Ag only
2. O- and H-antigens
3. О-, H-, and K-antigens+
4. О-, H-, K- and Vi-antigens
5. O- and K-antigens
48. Growth characteristics of E. coli on EMB agar:
1. Dark blue lactose-positive colonies^
2. Red lactose-positive colonies
3. Transparent lactose-negative colonies
4. Pinkish lactose-positive colonies
5. Dark blue lactose-negative colonies
49. Mechanism of verotoxin action:
1. Pore-forming toxin
2. Superantigen
3. Activator of secondary intracellular messengers
4. Proteolytic activity
5. Inhibitors of cellular protein synthesis+
50. Most frequent of E. coli opportunistic infections:
















5. Transfected DNA from external source














55. Most severe complication of enterohemorrhagic E. coli infections:
1. Acute heart failure
2. Hemolytic uremic syndrome with acute renal failure+
3. Massive water loss
4. Electrolyte disturbances
5. Septicemia
56. Typical morphology of shigellae:
1. Gram-negative non-motile rods+
2. Gram-positive motile rods
3. Gram-positive non-motile rods
4. Gram-negative non-motile rods with spores
5. Gram-negative motile bacteria






58. Biochemical property, typical for all enterobacteria:
1. Lactose fermentation
2. Potent proteolytic activity




59. Antigen composition of S. flexneri:
1 .0-Ag only
2. O- and H-antigens
3. О-, H-, and K-antigens
4. O- and K-antigens+
5. О-, H-, K- and Vi-antigens
60. Antigenic formula of the most aggressive enterohemorrhagic E. coli:
1.0111 :H 8
2. 026 : H2
3. 055 :H10
4. 0104 : H3
5. 0157: H7+
61. Mechanism of £. coli enterotoxin action:
1. Pore-forming toxin
2. Superantigen
3. Activator of secondary intracellular messengers+
4. Inhibitors of cellular protein synthesis
5. Metal-dependent protease
62. Pathogenic E. coli representatives very similar with shigellae:
1. Enteropathogenic E. coli
2. Enterohemorrhagic E. coli+
3. Uropathogenic E. coli
4. Enteroaggregative E. coli
5. Enterotoxigenic E. coli
63. Minimal infectious dose for enterohemorrhagic E. coli infection:
1 . 1-10 0  cells+
2. 100-300 cells 
3.300-1000 cells
4. Several thousands
5. 100 000 and more
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5. Any species is the potential agent of massive water-bom outbreaks 
of shigellosis
65. Futile method for laboratory diagnosis of shigellosis:
1. Bright field microscopy+
2. Planting on McConkey agar
3. Russel’s medium culturing
4. Determination of antigenic properties
5. Determination of carbohydrate fermentation
66. Molecular mechanism ensuring shigella intercellular lateral spread:
1. Cellular membrane engulfment
2. Transportation by phagocytes
3. Vacuole formation
4. Actin comet formation+
5. Flagella movement
67. Typical morphology of salmonellae:
1. Gram-negative non-motile rods
2 . Gram-positive non-motile rods
3. Gram-positive motile rods
4. Gram-negative motile rods+
5. Gram-negative comma-shaped bacteria
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68. One of the most common causative agents of salmonellosis with 
gastroenteritis:
1. S. Typhi










70. Growth characteristics of salmonellae on McConkey agar:
1. Red lactose-positive colonies
2. Dark blue lactose-positive colonies
3. Pinkish lactose-positive colonies
4. Dark blue lactose-negative colonies
5. Transparent lactose-negative colonies+
71. Salmonellae representatives, devoid of ability to produce hydrogen 
sulfide:
1. S. Typhimurium
2. S. Paratyphi A+




72. Kauffmann-White scheme of salmonella serotyping comprises:
1. Group determination according to specific O-Ag fraction followed 
by species identification by first phase of H-Ag+
2. Group determination according to specific O-Ag fraction followed 
by species identification by second phase of H-Ag
3. Group determination according to common O-Ag fraction followed 
by species identification by second phase of H-Ag
4. Group determination according to specific phase of H-Ag followed 
by species identification by specific O-Ag fraction
5. Group determination according to specific O-Ag fraction followed 
by species identification by Vi-Ag




3 .  CD16
4. CD32
5. CD35
74. The material for microbial examination should be taken at the first 






75. Laboratory test for detection of salmonella carriers:
1. Widal’s test tube agglutination
2. Cultural method
3. Luminescent microscopy
4. Indirect Vi-hemagglutination test+
5. Kauffmann-White agglutination test
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76. Elevated level of antibodies in enteric fever convalescent persons 
results from:
1. Anti-Vi-Ag antibodies
2. Anti-O-Ag antibodies more than anti-H-Ag antibodies
3. Anti-H-Ag antibodies more than anti-O-Ag antibodies+
4. Anti-K-Ag antibodies
5. Anti-enterotoxin antibodies
77. Vaccine currently used for enteric typhoid fever prophylaxis
1. Inactivated cellular vaccine
2. Chemical Vi-Ag-based vaccine+
3. Chemical O-Ag-based vaccine
4. Typhoid toxoid
5. DNA vaccine














80. Salmonella members, able to ferment lactose with acid end products:
l.S . Typhi+
2. S. Typhimurium
3. S. Paratyphi A
4. S. Paratyphi В
5. S. Enteritidis
81. Antigen composition of S. Typhi:
1 .0-Ag only
2. O- and H-antigens
3. О-, H-, and sometimes Vi-antigens+
4. О-, H-, K- and Vi-antigens
5. O- and K-antigens
82. Mechanism of salmonella enterotoxin action:
1. Pore-forming toxin
2. Superantigen
3. Activator of enterocyte adenylate cyclase+
4. Inhibitor of enterocyte protein synthesis
5. Invasion enzyme













85. Minimal infectious dose for S. typhr.
1 . 102 cells+








4. Bismuth sulfite agar+
5. Endo medium
87. Serological criteria for acute enteric fever infection:
1. Serum titer of antibodies to O-Ag is 1/50, titer of antibodies to H- 
A g - 1/200
2. Serum titer of antibodies to O-Ag is 1/40, titer of antibodies to H- 
A g -  1/40
3. Serum titer of antibodies to O-Ag is 1/400, titer of antibodies to H- 
A g - 1/200+
4. Serum titer of antibodies to O-Ag is 1/100, titer of antibodies to H- 
A g - 1/100
5. Serum titer of antibodies to Vi-Ag is 1/40







89. Typical morphology o f cholera causative agent:
1. Gram-positive motile spiral agent
2. Gram-negative motile peritrichous bacteria
3. Gram-negative comma-like monotrichious bacteria+
4. Gram-positive motile comma-shaped agent
5. Gram-negative motile sporeforming rod
90. 0139 vibrio can evade population immunity owing to:
1. Alteration of LPS-coding genetic cluster+
2. H-antigen phase change
3. Capsule uptake
4. Loss of toxin producti on
5. Antigenic mimicry
91. Main factor of cholera vibrio virulence:
1. Endotoxin




92. Growth characteristics of yersiniae on Endo medium:
1. Pinkish lactose-positive colonies
2. Transparent lactose-negative colonies+
3. Red lactose-positive colonies
4. Dark blue lactose-positive colonies
5. Deep red lactose-negative colonies
93. Biochemical test that makes possible to 








94. Vibrio receptor for CTX phage:
1 . TCP pili+
2. 0139 LPS
3. Type III pili
4. Needle complex
5. Mannose-sensitive hemagglutinin
95. Mechanism of C. botulinum neurotoxin action:
1. Pore-forming toxin affecting neuronal membranes
2. Superantigen affecting neuronal membranes
3. Activator of secondary intracellular messengers
4. Inhibitor of synaptic protein synthesis
5. Specific protease destroying synaptic proteins+
96. Infectious dose for V cholerae:
1 . 102 cells
2 . 103 cells
3. 104 cells
4. 105 cells
5. 106 cells or more+






98. Vaccine used for specific prophylaxis of yersinioses:
1. Inactivated vaccine
2. Attenuated live vaccine
3. Chemical vaccine
4. Sub-unit vaccine
5. None of above listed+
1. Antibiotics administration
2. Injections of polyvalent antitoxic sera+
3. Toxoid administration
4. Infusion therapy for detoxication
5. Urgent vaccination
99. Urgent treatment o f botulism:






101. Typical morphology of Yersinia pseudotuberculosis'.
1. Gram-negative non-motile rods
2. Gram-positive non-motile rods
3. Gram-positive motile rods
4. Gram-negative motile rods+
5. Curved or branched acid-fast bacteria
102. Cholera vibrio becomes virulent owing to:
1. Bacterial transformation




103. Antigenic composition of V. cholerae
1. O-Ag
2. O- and H-antigens+
3. О-, H-, and K-antigens
4. S-, R-, and H-antigens
5. O- and K-antigens






105. Life-threatening complication of cholera:
1. Watery diarrhea








4. Positive indole test
5. Agglutination test with Ol and 0139 antisera+
107. Yersinia pseudotuberculosis virulence is predominantly encoded by:
1. Plasmid with pathogenicity island+
2. Nucleoid with pathogenicity island
3. Transposon
4. Temperate bacteriophage
5. DNA from external source with pathogenicity island
108. Minimal sterilization regimen ensuring complete botulotoxin 
inactivation:
1. Heating at 56°C for 30 minutes
2. Heating at 80°C for 30 minutes
3. Boiling for 1 minute
4. Boiling for 5 minutes
5. Boiling for 10 minutes ormore+
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109. Urgent treatment of cholera:
1. Antitoxic sera injections
2. Antibacterial drug administration
3. Compensatory infusion therapy+
4. Toxoid administration
5. Urgent vaccination
110. Specific symptoms, indicating manifested botulism onset:
1. Diarrhea
2. Severe headache, dizziness
3. Vomiting, nausea
4. Swallowing troubles, aphonia, diplopia+
5. Dry mouth
111. Morphology of meningococci:
1. Gram-positive long chains
2. Gram-positive bean-shaped diplococci
4. Gram-negative bean-shaped diplococci+
3. Gram-negative short chains
5. Gram-negative irregular cocci












1. Outer membrane protein antigens
2. Lipooligosaccharide antigens
3. IgA proteases
4. Antigens of pili
5. Capsular antigens+
114. M eningococcal serogroup is determined by:
115. Most suitable clinical specimen for whooping cough laboratory 
diagnosis:
1. “Cough plate” sample
















118. The symptom, indicating meningococcemia emergence:
1. High fever
2. Rigidity of occipital muscles
3. Severe headache
4. Petechiac rash+
5. Leukocyte presence in cerebrospinal fluid






120. Specific prophylaxis of whooping cough is performed by:
1. Patients isolation
2. Human immunoglobulin administration
3. Pertussis toxoid
4. BCG vaccine
5. DTP vaccine (cellular or acellular)+






122. Typical morphology of whooping cough causative agent:
1. Gram-negative oval-shaped capsulated small rods+
2. Gram-positive non-sporeforming rods
3. Gram-positive bacilli
4. Gram-negative sporeforming capsulated rods
5. Gram-negative bean-shaped diplococci
123. Morphological property, essential for mycoplasmas:
1. Small sizes
2. Intracellular persistence










125. Pertussis toxin action:
1. Intracellular protease activity
2. ADP-ribosylating activity with activation of secondary cellular 
messengers+
3. Disruption of cell membrane
4. Protein synthesis inhibition
5. Increase of vascular permeability




4. Outer membrane protein antigens+
5. Cytoplasmic antigens










4. Patient with menigococcemia
5. Patient’s nasal secretion
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129. Minimal significant rise of specific antibody titers for laboratory 





5. Greater than 10 times







131. Polysaccharide quadrivalent vaccine confers immunity against 

























135. Acid-fastness of tubercle bacilli depends on:
1. Thick cell wall
2. Mycolic acid presence-t-
3. Teichoic acid presence
4. LPS presence
5. Capsule presence




4. Catalase positive test
5. Growth on salycilate-containing media




4. Waxes and phosphatides
5. Protein complex-!-






139. Medium for culturing of C. diphteriae:
1. Lowenstein-Jensen’s medium










141. Minimal protective titer of diphtheria antitoxin in humans, evaluated 






142. BCG vaccine confers:
1. Active sterile immunity
2. Passive sterile immunity
3. Passive non-sterile immunity
4. Active non-sterile immunity+
5. Active anti-toxic immunity
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143 Tuberculin skin test estimates:
1. Ist type anaphylactic hypersensitivity in tuberculosis
2. IInd type cytotoxic hypersensitivity
3. IIIrd type immune complex-mediated hypersensitivity
4. IVth type cell-mediated hypersensitivity+
5. Anti-receptor autoimmune reactions
144. Mycobacterium that can cause tuberculosis in humans:
1. M  kansasii
2. M. microti
3. M  bovis+
4. M. smegmatis
5. M. avium











5. None of above listed
147. Mechanism of diphtheria exotoxin action:
1. Pore-forming toxin
2. Cytotoxic superantigen
3. Activator of secondary intracellular messengers
4. Metal-dependent protease with cytotoxic activity
5. Inhibitor of cellular protein synthesis via peptide elongation cease+
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4. Clauberg II medium
5. Tinsdal medium












151. Most sensitive and rapid method for diphtheria toxin detection:
1 . PCR+
2. Neutralization reaction on mice
3. Cell cultural test
4. Flocculation reaction
5. Immune diffusion
152. The main intervention in urgent therapy of diphtheria:
1. Toxoid administration
2. Treatment with specific serum in sufficient doses+
3. Antibiotic treatment in sufficient doses
4. Massive infusion therapy for detoxication
5. Urgent DPT injections







154. Multi-drug resistant or MDR M. tuberculosis demonstrates:
1. Resistance to pyrazinamide and streptomycin
2. Resistance to isoniazid and streptomycin
3. Resistance to rifampin and streptomycin
4. Resistance to isoniazid and rifampin+
5. Resistance to rifampin and fluoroquinolones
155. Morphology of plague causative agent:
1. Gram-positive rods
2. Gram-negative ovoid rods+
3. Gram-positive bipolar cocci
4. Gram-negative long rods
5. Gram-negative irregular cocci











































163. Skin test with tularin predominantly evaluates:
1. Cell-mediated delayed hypersensitivity+
2. Anaphylactic hypersensitivity
3. Cytotoxic hypersensitivity
4. Immune complex-mediated hypersensitivity
5. Antibody-dependent cell cytotoxicity




4. Killed non-capsulated vaccine
5. Recombinant vaccine
165. Y. pestis aggressively dampens host immune response resulting in:
1. T helper cells blockade
2. NK cells attrition
3. Severe phagocytosis inhibition+
4. Thymocytes maturation arrest
5. Awry antibody synthesis by plasma cells
166. Morphology of B. anthracis:
1. Gram-positive non-sporeforming large rods
2. Gram-positive sporeforming capsulated large rods+
3. Gram-positive oval-shaped capsulated cocci
4. Gram-negative non-sporeforming large rods
5. Gram-negative motile large rods












3. Cell wall structure
4. Injectisome presence
5. Nothing of above listed




4. Crumpled lace handkerchieff
5. Globules of mercury
170. Test for B. anthracis antigen detection in various raws (skin, hair, 
etc.):
1. Indirect hemagglutination
2 .  PCR
3. Complement fixating test
4. Agglutination reaction
5. Thermoprecipitation+













173. These media can be used for brucellae and francisellae cultivation 
except:
1 . Chocolate agar
2. Serum agar with cystein
3. Meat-peptone agar+
4. Glucose blood agar
5. Liver extraction agar






175. Vaccine for tularemia prophylaxis:
1. Killed vaccine
2. Subunit vaccine




176. Molecular mechanism o f anthrax lethal toxin action:
1. Membrane damage (pore-forming toxin)
2. Activation of CD95-mediated apoptosis
3. Stimulation of adenylate cyclase resulting in tissue edema
4. Deregulation of intracellular signal transmission -  hydrolysis of 
MAPK-kinase+
5. Superantigen triggering systemic inflammatory response






178. Morphology of T. pallidum:
1. Comma-like twisted bacteria
2. Spirochetes with large hooks on the ends
3. Branched flagellated bacteria
4. Twisted bacterial forms with 8-15 regular coils+
5. Spirochetes with loose irregular large coils




4. Cell wall absence+
5. Accelerated efflux of beta-lactams
180. Minimal infectious dose of treponemas that can cause syphilis:
1. Several microbial cells+
2. About 100 cells
3. In the range 102-103 cells
4. 103-104 cells
5. More than 105 cells
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4. Treponemal immobilization test
5. Microscopy+





5. None of above listed
184. Main complication in gonorrhoea:
1 . Infertility+
2. Generalization of disease
3. Immunodeficiency
4. Endocarditis
5. Progression of other sexually transmitted diseases










3. Tetracyclines or macrolides+
4. Vancomycin
5. Amphotericin В
187. The origin of expanding treatment failures in gonorrhoea:
1. Growing disease incidence
2. Intracellular persistence of gonococci
3. Incomplete phagocytosis of bacteria
4. Elevated cost of treatment
5. Rapidly progressing gonococcal resistance to antibiotics+
188. These traits are equal in gonococci and meningococci except:
1. Gram-negative cell wall
2. Bean-shaped diplococci
3. Require special media for growth
4. Flagella absence
5. Capsule presence*
189. Gonococci can grow:
1. In anaerobic conditions
2. In media with bile salts
3. In serum or ascitic agar+
4. In ordinary media
5. At room temperature
190. This statement is incorrect for chlamydiae:
1. Grow in special nutrient media*
2. Elementary bodies are the invasive form of chlamidiae
3. Can grow in various cell lines
4. Cannot synthesize ATP
5. Doxycycline is effective in chlamydiosis treatment
118












193. All these tests are specific in syphilis except:
1. Fluorescent treponemal antibody absorption test
2. T. pallidum immobilization test
3. VRDL reaction+
4. Wasserman reaction with treponemal antigen
5. Microhemagglutination test







195. Prevention of syphilis is achieved by:
1. Autovaccine administration
2. Multiple injections of killed vaccine
3. Vaccination with live attenuated vaccine
4. Single dose administration of recombinant vaccine
5. Non-specific prophylaxis+
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197. Method for prevention of ophthalmia neonatorum in newborns:
1. Vaccination
2. Passive prophylaxis
3. Systemic antibiotic treatment
4. Eye instillations with antibiotics or antiseptics+
5. Disinfection of linen and utensils
198. Wasserman reaction is based on:
1. Precipitation test
2. Microhemagglutination test
3. Complement fixation test+
4. ELISA test
5. T. pallidum immobilization test










































206. The main route of transmission for Lyme disease:
1. Via louse bite
2. Via louse crush with subsequent rubbing of louse hemolymph
3. Via tick bite+
4. Via flea bite
5. Via rodent bite
207. Choose the anthroponotic disease:
1. Leptospirosis
2. Rocky Mountain spotted fever
3. Epidemic relapsing fever+
4. Endemic typhus
5. Lyme borreliosis






209. Predominant route of transmission in Q-fever:
1. Air-dust or air-droplet route+
2. Contact route
3. Parenteral route
4. Via louse bite
5. Water route
















4. Dark field microscopy
5. Neisser stain












215. Current emerging diseases:
1. Typhoid diseases
2. Rickettsioses from spotted fever group+
3. Epidemic relapsing fever
4. Leptospirosis
5. Brill-Zinsser disease
216. The most routinely used method for diagnosis of epidemic relapsing 
fever:
1. Blood culture isolation














4. Cytoplasm and nuclei of affected cells
5. Cytoplasm of endothelial cells+
219. First clinical finding in Lyme disease:





220. Post-exposure prophylaxis of Lyme disease after tick bite includes:
1. Medical observation of affected person
2. Early vaccination in 1-3 days
3. Passive protection with human immunoglobulin
4. Course treatment with amoxicillin or doxycycline+




1. The basic viral property:
1. Contains protein-synthesis systems
2. Capable to grow on simple nutrient media
3. Extracellular propagation
4. Intracellular parasitism+
5. Devoid of nucleic acid
2. Impossible variant of viral genome:
1. Single-stranded RNA
2. Double-stranded RNA
3. Pair of identical RNA
4. Double-stranded DNA
5. Double-stranded DNA-RNA complex+
3. The methods, used for laboratory diagnosis of viral infections:
1. Immune state evaluation
2. Paired sera serological test+
3. Inoculation into nutrient medium
4. Biochemical properties evaluation
5. None of above listed
4. Mode of viral nucleic acid replication for positive-sense single-stranded 
RNA viruses:
1. Positive-sense RNA transcribed to positive-sense RNA
2. Positive-sense RNA transcribed to negative-sense RNA
3. Positive-sense RNA transcribed to DNA then to positive-sense 
RNA
4. Positive-sense RNA transcribed to DNA then to negative-sense 
RNA
5. Positive-sense RNA transcribed to negative-sense RNA then to 
positive-sense RNA+
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1. Negative-sense RNA transcribed to negative-sense RNA then 
translated to the protein
2. Negative-sense RNA transcribed to positive-sense RNA then 
translated to the protein+
3. Negative-sense RNA is translated to the protein
4. Negative-sense RNA transcribed to DNA then translated to the 
protein
5. Negative-sense RNA transcribed to DNA, next into positive-sense 
RNA and then translated to the protein
5. M ode o f  viral protein synthesis for negative-sense single-stranded RNA
viruses:
























5. 1000 and more
10. Method of viral identification:











12. The essential feature of viruses:
1. Viral envelope is covered with capsule
2. Need cell machinery for replication+
3. Cellular structure
4. Energy gain from biological oxidation
5. Contain both types of nucleic acid
13. The main parameter for modem classification of viruses:
1. Viral size
2. Symmetry type
3. Nucleic acid sequence+
4. Physical and chemical properties
5. Type of natural host
1. Negative-sense RNA transcribed to negative-sense RNA
2. Negative-sense RNA transcribed to positive-sense RNA
3. Negative-sense RNA transcribed to DNA then to negative-sense 
RNA
4. Negative-sense RNA transcribed to positive-sense RNA then to 
negative-sense RNA+
5. Negative-sense RNA transcribed to DNA then to positive-sense 
RNA
14. Mode o f  viral nucleic acid replication for negative-sense single-
stranded RNA viruses:
15. Mode of viral protein synthesis for positive-sense single-stranded RNA 
viruses:
1. Positive-sense RNA is translated to the protein+
2. Positive-sense RNA transcribed to positive-sense RNA then 
translated to the protein
3. Positive-sense RNA transcribed to negative-sense RNA then 
translated to the protein
4. Positive-sense RNA transcribed to DNA then translated to the 
protein
5. None of above listed
16. Mode of viral nucleic acid replication for retroviruses:
1. Retroviral RNA transcribed to negative-sense RNA
2. Retroviral RNA transcribed to positive-sense RNA
3. Retroviral RNA transcribed to DNA then to RNA+
4. Retroviral positive RNA transcribed to negative-sense RNA then to 
positive RNA
5. Retroviral ambisense RNA positive fragments are transcribed to 
negative-sense RNA then to positive RNA
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5. Cell tumor transformation






20. The origin of the cells for continuous cell cultures:
1. Primary skin fibroblast culture
2. Monkey kidney culture
3. Human embryo cells
4. Human malignant cells+
5. Chicken embryo cells
21. Method of viral detection (viral indication):
1. Cytopatic effect neutralization
2. Hemadsorbtion inhibition
3. Hemagglutination inhibition test
4. Complement fixation test
5. Syncytium formation+




4. Infection of laboratory animals
5. Chicken embryo inoculation












5. Phage nucleic acid












5. Phage release (egress)
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27. Disjunctive type of phage reproduction means:
1. Phage components are synthesized in separate bacterial cell 
compartments followed by next virion assembly+
2. Phage replication occurs in special separated cell compartment
3. Sequential (step-by-step) synthesis of phage components
4. Repeated temporary termination of synthesis of phage proteins and 
nucleic acid
5. Replication of phage nucleic acid precedes the synthesis of viral 
proteins
28. Phage (or lysogenic) conversion means:
1. Transformation of DNA-containing phages into RNA-containing 
ones
2. Activation of latent phages
3. Disassembling of phage particle
4. Bacterial cell acquires new features as the result of prophage gene 
expression+
5. Lysis of bacterial cell by offspring phage particles
29. Prophage is:
1. Parental bacteriophage primarily present in bacterial cell
2. Nucleic acid of temperate phage integrated into bacterial genome+
3. Immature phage
4. Senescent degrading phage particle
5. Dormant phage particle present in bacterial cytoplasm
30. Integration of phage DNA into bacterial chromosome occurs due to:
1. Spontaneous mutations
2. Induced mutagenesis
3. Site-specific recombination of bacterial and viral DNA+
4. Incorrect reparation of bacterial genome
5. Error-prone replication of bacterial DNA
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31. Lysogenic conversion can generate:
1. Exotoxin production by bacteria
2. Change of structure of bacterial cell wall
3. Synthesis of invasive enzymes
4. Antibiotic resistance
5. All above mentioned is true+
32. Phage titer in liquid medium test means:
1. Certain tube dilution of bacteriophages
2. Last dilution of phage culture able to cause complete inhibition of 
bacterial growth in standard experimental conditions+
3. Total count of phage particles
4. Total number of phage plaques
5. Minimal amount of specific antibodies completely inactivating standard 
number of phages
33. Phagotyping implies:
1. Identification of narrow bacterial population susceptible to highly 
specific bacteriophages+
2. Accumulation of phage particles in liquid or solid medium
3. Classification of phages according to their properties
4. Identification of bacteria harboring specific phage genome
5. Transduction of bacterial culture
34. Structural properties of orthomyxoviruses:
1. Helical symmetry, rod-shaped
2. Icosahedral symmetry, break-shaped
3. Helical symmetry, spherical shape+
4. Complex symmetry, spherical shape
5. Icosahedral symmetry, rod-shaped
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35. Gene drift of influenzaviruses means:
1. Genetic translocations of viral structural genes
2. Point mutations within hemagglutinin and neuraminidase genes+
3. Genetic reassortment of hemagglutinin and neuraminidase gene 
segments
4. Gene transfer from avian to human host
5. Change of influenzavirus type




4. Type В and C
5. None of above listed





5. Acute hemorrhagic cystitis






39. Paramyxoviridae representative, able to affect reproductive system:
1. Parainfluenza virus
2. Morbillivirus
3. Respiratory syncytial virus
4. Mumps virus+
5. All above listed
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1. Hemagglutination inhibition test
2. Neutralization of cytopathic effect+
3. Hemadsorbtion inhibition test
4. Hemadsorbtion test
5. Plaque formation
40. Test for respiratory syncytial virus identification:
41. Paired sera test is considered to be significant in case of antibodies titer 
rise:
1. Twofold
2. Fourfold and more+
3. Eightfold and more
4. Tenfold and more
5. There are no established limits
42. Trivalent vaccine for respiratory disease prophylaxis is composed of:
1. Live parainfluenza virus, mumps virus, measles virus
2. Live influenza virus, mumps virus, measles virus
3. Inactivated influenza virus, live mumps virus and measles virus
4. Live rubella virus, influenza virus, measles virus
5. Live rubella virus, mumps virus, measles virus+
43. Most suitable vaccine for respiratory syncytial virus infection 
prophylaxis:
1. Inactivated vaccine
2. Attenuated live vaccine
3. Subvirion vaccine
4. Subunit vaccine
5. None of above listed+
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1. Cell culture
2. Hemagglutionation inhibition test
3. Infection of laboratory animals
4. PCR+
5. Neutralization of cytopathic effect
44. Most efficient method for SARS virus laboratory diagnosis:













5. Respiratory syncytial virus+
47. Genetic shift of influenzaviruses means:
1. Genetic reassortment of hemagglutinin and neuraminidase genes+
2. Influenzavirus genes movement along the host cell chromosome
3. Influenza gene transfer from swine to human hosts
4. Point mutations within hemagglutinin and neuraminidase genes
5. Genetic reassortment of influenzavirus gene, encoding RNA- 
polymerase
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48. Structural properties of paramyxoviruses:
1. Helical symmetry, spherical shape+
2. Icosahedral symmetry, rod-shaped
3. Naked virus, rod-shaped
4. Enveloped virus, icosahedral symmetry
5. Complex symmetry, spherical shape











5. None of above listed
51. Express-method of influenza laboratory diagnosis:
1. Hemagglutination test
2. Hemagglutination inhibition test
3. Complement fixation test
4. Neutralization of chicken embryo death
5. Immunofluorescent test+
52. Test for parainfluenza virus identification:




5. Cytopathic effect detection





5. Respiratory syncytial infection
54. Vaccine for mumps prophylaxis:
1. Inactivated vaccine




55. Influenza virus strain with highest pathogenic potential:
1. H,Ni




56. Structural properties of picomaviruses:
1. Single-stranded DNA naked virus
2. Double-stranded DNA enveloped virus
3. Positive-sense RNA naked virus+
4. Negative-sense RNA enveloped virus
5. Positive-sense RNA enveloped virus
57. Structural properties of rotaviruses:
1. Double-stranded DNA naked virus
2. Diploid positive RNA enveloped virus
3. Ambisense segmented single-stranded RNA enveloped virus
4. Double-stranded RNA-segmented naked virus with 2 capsids-t-
5. Positive-sense RNA naked virus
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5. None of above listed
61. These methods are used for Coxsackie infection diagnosis except:
1. Inoculation of virus-containing material into tissue cultures
2. Inoculation of virus-containing material into suckling mice
3. ELISA
4. Inoculation of virus-containing material into cell-free medium+
5. Hemagglutination inhibition test







63. Method that is not used for poliomyelitis laboratory diagnosis:
1. Hemagglutination test+
2. Cell line cultivation
3. Cytopathic effect determination
4. Serologic testing
5. Neutralization reaction






65. The most severe adenoviral infection of early postnatal period:
1. Adenoviral gastroenteritis
2. Adenoviral pneumonia-t-
3. Acute hemorrhagic cystitis
4. Acute febrile pharyngitis
5. Epidemic keratoconjunctivitis
66. The major causative agents of infant’s gastroenteritis





67. Structural properties o f adenoviruses:
1. Double-stranded DNA naked virus+
2. Double-stranded DNA enveloped virus
3. Positive-sense RNA naked virus
4. Negative-sense RNA enveloped virus
5. Positive-sense RNA enveloped virus











5. Hepatitis A virus
70. “Swimming pool conjunctivitis” is caused by:
1. Coxsackie virus group A




71. Main cellular targets for polioviruses
1. Striated muscular cells
2. Epithelial cells
3. Glial cells
4. Spinal cord motoneurons+
5. Axons of peripheral nerves
72. Antibodies of IgG and IgA classes against polioviruses are present in 
most of human population because of:
1. Broad spread of sub-clinical infection
2. Viral latency (intestinal viral carriage)
3. Viral persistence within immune system
4. Previous immunization with live vaccine+
5. Previous immunization with inactivated vaccine
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73. The virus -  candidate for global elimination in nearest future:
1. Hepatovirus
2. Enterovirus serotype 70
3. Adenovirus serotype 21
4. Rotavirus
5. Poliovirus+
74. Clinical specimen for poliovirus detection should be taken from:
1. Rectal swab or stool specimen
2. Urine
3. Nasopharingeal swab
4. Nasopharingeal swab and stool specimen+
5. Blood
75. Viral agents that predominantly affect inner organs:
1. Rotaviruses
2. Polioviruses
3. Coxsackie viruses of group A
4. Coxsackie viruses of group B+
5. Echoviruses
76. Basic treatment of rotaviral infection:
1. Restoring of water and electrolyte balance with compensatory 
infusion therapy+
2. Administration of anti-viral drugs
3. Antibiotic treatment
4. Intravenous immunoglobulin administration
5. Urgent vaccination





5. None of above listed, vaccine remains unavailable yet+
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5. Hepatitis C and HIV mixed infection
80. Immune cells that store and disseminate HIV:
1. T-helper CD4(+) cells
2. B-cells
3. Neutrophils
4. Macrophages and monocytes+
5. Cytotoxic CD8(+) T-cells













83. Hepatites transmitted predominantly by fecal-to-oral route:
1. Hepatitis A, Hepatitis В
2. Hepatitis A, Hepatitis C, Hepatitis В
3. Hepatitis A, Hepatitis B, Hepatitis E
4. Hepatitis A, Hepatitis B, Hepatitis D
5. Hepatitis A, Hepatitis E+







85. Efficient vaccine for hepatitis A prophylaxis:
1. Vaccine is absent
2. Inactivated vaccine+
3. Attenuated live vaccine
4. Recombinant vaccine
5. Subunit peptide vaccine
86. Highly active antiretroviral therapy includes:
1. Treatment with reverse transcriptase inhibitors
2. Combination of reverse transcriptase inhibitors and viral integrase 
inhibitors
3. Combination of reverse transcriptase inhibitors and 
immunostimulatory drugs
4. Combination of reverse transcriptase inhibitors and viral protease 
inhibitors+
5. Combination of nucleoside and non-nucleoside reverse transcriptase 
inhibitors
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5. Co-infection with Hepatitis В and delta viruses





5. Reverse transcriptase PCR
90. Successful penetration of HIV into susceptible cell is achieved via:
1. Cellullar CD1 antigen
2. Cellullar adrenoreceptors, associated with G proteins
3. Cellullar CD8 antigen and TNF receptor
4. Cellullar CD4 antigen and CXCR4 or CCR5+
5. Cellullar CD4 antigen and GM CSF receptor
91. HIV infection is contracted via the following routs of transmission 
except:
1. Intravenous drug use
2. Vertical rout
3. Contact rout (contact with patient’s saliva)+
4. Contact rout (sexual intercourse)
5. Artificial rout
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92. Critical blood levels of T helper cells resulting in AIDS development:
1. Number of T helper cells is in the range of 1000-1500 cells per 1 
microliter (ul)
2. Less than 1000 cells but more than 500 cells per 1 ul
3. 200-500 T helper cells per 1 ul
4. Less than 200 cells per 1 ul+
5. Less than 100 cells per 1 ul






94. First clinical manifestations in HIV infection:
1. Persistent generalized lymphoadenopathy










96. Hepatites, which can be transmitted by artificial route:
1. Hepatitis C, Hepatitis В
2. Hepatitis C, Hepatitis B, Hepatitis E
3. Hepatitis A, Hepatitis E
4. Hepatitis A, Hepatitis B, Hepatitis D
5. Hepatitis C, Hepatitis D, Hepatitis B+
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97. Hepatitis virus, showing greatest genetic diversity:
1. Hepatitis A virus
2. Hepatitis В virus
3. Hepatitis C virus+
4. Hepatitis D virus
5. Hepatitis E virus
98. Vaccine for hepatitis В prophylaxis:
1. Recombinant vaccine+
2. Subvirion vaccine with adjuvant
3. Subunit vaccine
4. Inactivated vaccine
5. Attenuated live vaccine
99. Most successful method for hepatitis C treatment:
1. Administration of reverse transcriptase inhibitors
2. Ribavirin treatment
3. Recombinant IL-2 treatment
4. Recombinant alpha-interferon treatment
5. Combined therapy with ribavirin and recombinant prolonged PEG- 
interferon+






101. Structural properties of lyssavirus:
1. Negative-sense RNA enveloped virus+
2. Positive-sense RNA naked virus
3. Diploid RNA enveloped virus
4. Positive-sense RNA enveloped virus





3. Herpes simplex virus
4. Herpesvirus of type 8
5. Cytomegalovirus+


















106. Most serious rubella complication:
1. Arthritis development




1. Positive-sense RNA naked virus
2. Negative-sense RNA enveloped virus
3. Diploid RNA enveloped virus
4. Positive-sense RNA enveloped virus
5. Double-stranded DNA enveloped virus+
107. Structural properties o f herpesviruses:
108. Rabies treatment in case of animal multiple bites into head and upper 
extremities:
1. Specific vaccination
2. Anti-rabies immunoglobulin treatment
3. Anti-rabies immunoglobulin treatment combined with vaccination+
4. Specific vaccination combined with interferon treatment
5. Anti-rabies immunoglobulin administration combined with 
antibiotic treatment
109. Vaccine for rubella prophylaxis:
1. Attenuated live vaccine+
2. Inactivated vaccine
3. Subvirion vaccine with adjuvant
4. DNA vaccine
5. Recombinant vaccine
110. The virus that exerts specific tumor in AIDS patients
1. Herpesvirus of type 8+
2. Herpesvirus of type 6




111. Structural properties of rubella virus:
1. Positive-sense RNA naked virus
2. Negative-sense RNA enveloped virus
3. Circular single-stranded DNA enveloped virus
4. Positive-sense RNA enveloped virus+





4. Herpes simplex virus
5. Herpesvirus of type 6
113. Structural properties of roseoloviruses:
1. Positive-sense RNA enveloped virus
2. Negative-sense RNA enveloped virus
3. Double-stranded DNA enveloped virus+
4. Circular double-stranded DNA enveloped virus
5. Double-stranded DNA naked virus
114. Herpesvirus transmitted predominantly by sexual intercourse:
1. Herpesvirus of type 1
2. Herpesvirus of type 2+
3. Herpesvirus of type 3
4. Herpesvirus of type 4
5. Herpesvirus of type 5




4. Herpesvirus of type 8
5. Epstein-Barr virus
116. Mortality rate in manifested rabies:




5. Less than 20% if treated
117. The way rabies vims spreads from primary lesion:
1. By blood
2. By lymph
3. Within immune cells
4. Via peripheral nerves+
5. All above listed
118. Viral entry of Epstein-Barr vims into В cells occurs via:
1 . CD19
2. CD20
3 .  CD21+
4 .  CD5
5. CD40






120. The virus -  potential agent of carcinogenesis:
1. Rubella virus
2. Epstein-Barr vims+
3. Herpes simplex vims






5. T cell leukemia
121. Herpesvirus type 8 can cause:






123. Molecular origin of prion diseases:
1. Overproduction of PrPc proteins
2. Expression of PrPSc proteins; the latter spread their altered 
conformation towards normal PrPc proteins+
3. Enhanced expression ofPRNP gene
4. Dampening of intracellular proteasome activity
5. Self-aggregation of serum amyloid
124. Primary tissues and organs affected in prion diseases:
1. Cardiovascular system





125. Prion disorders are characterized by following histopathological 
changes:
1. Spongiform degeneration and atrophy, amyloid plaques+
2. Multifocal sclerosis
3. Vasculitis and microhemorrhages
4. Systemic inflammation
5. Tissue edema
126. Acquired form of prion disease:
1. Gerstmann-Straussler-Scheinker syndrome
2. Sporadic form of Creutzfeldt-Jakob disease
3. “New variant” of Creutzfeldt-Jakob disease+
4. Fatal familial insomnia
5. Alpers syndrome




4. Contact rout of transmission
5. Results from ritual cannibalism+
128. Prion disease characterized by sleeplessness, mental disorders, and 
endocrine dysfunction:
1. Kuru disease
2. Sporadic form of Creutzfeldt-Jakob disease
3. “New varianf ’ of Creutzfeldt-Jakob disease
4. Fatal familial insomnia+
5. Gerstmann-Straussler-Scheinker syndrome
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129. Human prion disease transmitted by alimentary route with infected 
beef:




5. “New variant” of Creutzfeldt-Jakob disease+
130. The ailment with suspected prion origin:
1. Schizophrenia
2. Sub-acute sclerosing panencephalitis
3. Senile dementia
4. Alzheimer’s disease+
5. Chronic fatigue syndrome
131. Diagnosis of prion diseases is based on:
1 . PCR
2. Molecular hybridization
3. Cytological examination of brain tissue on autopsy+
4. Cell culture testing
5. Neutralization test





5. None of above listed, anti-prion drugs are not elaborated yet+
133. These measures are used for prevention of acquired prion diseases 
except:
1. Vaccination+
2. Careful selection of donor’s tissues for transplantation
3. Tight control of medical sterilization
4. Burning of the carcasses of dead animals
5. Thorough veterinary surveillance
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№ A N SW ER 38 2 76 3
1 3 39 2 77 2
2 1 40 3 78 4
3 4 41 3 79 5
4 3 42 4 80 1
5 5 43 12 81 3
6 2 44 2 82 3
7 4 45 2 83 2
8 4 46 4 84 2
9 3 47 3 85 1
10 2 48 1 86 4
11 5 49 5 87 3
12 4 50 1 88 5
13 1 51 2 89 3
14 5 52 4 90 1
15 2 53 5 91 4
16 3 54 4 92 2
17 2 55 2 93 4
18 2 56 1 94 1
19 4 57 3 95 5
20 5 58 5 96 5
21 1 59 4 97 2
22 2 60 5 98 5
23 3 61 3 99 2
24 5 62 2 100 4
25 3 63 1 101 4
26 4 64 2 102 2
27 3 65 1 103 2
28 2 66 4 104 5
29 4 67 4 105 3
30 1 68 3 106 5
31 5 69 1 107 1
32 4 70 5 108 5
33 4 71 2 109 3
34 2 72 1 110 4
35 1 73 1 111 3
36 1 74 5 112 2
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